ENSO
Company

Last deal

$4.3M

Amount

Series A

Stage

09.04.2017

Date

2

all rounds

$7.2M

Total amount

General

About Company
ENSO has developed a wearable device that delivers a patented electrical stimulation treatment to solve pain better than Vicodin.

Industry

Sector :

Subsector :

Also Known As

Cur

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The ENSO device is a non-invasive, wearable medical device that delivers electrical pulses with a specialized waveform to suppress the activity of nerves in the area where it is applied. It is being used to solve chronic and acute pain at over 100 medical centers in the US and is covered by VA Hospitals and workers compensation insurance plans. The device is expected to be covered by major commercial insurance plans by 2021. It is thoughtfully designed for a seamless patient experience and is IoT-enabled with an app that tracks treatment use and patients' progress towards reducing pain and achieving lifestyle goals set when first using the device.
Contacts